Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Direct effects of thyroid hormones on hepatic lipid metabolism
Rohit A. Sinha, Brijesh Kumar Singh, Paul M. Yen
Nature Reviews Endocrinology (2018) Vol. 14, Iss. 5, pp. 259-269
Open Access | Times Cited: 497

Showing 1-25 of 497 citing articles:

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, et al.
Hepatology (2023) Vol. 77, Iss. 5, pp. 1797-1835
Open Access | Times Cited: 1116
The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System
Gholamreza Daryabor, Mohammad Reza Atashzar, Dieter Kabelitz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 434
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus
Daniel Ferguson, Brian N. Finck
Nature Reviews Endocrinology (2021) Vol. 17, Iss. 8, pp. 484-495
Open Access | Times Cited: 330
NAFLD: Mechanisms, Treatments, and Biomarkers
Fatiha Nassir
Biomolecules (2022) Vol. 12, Iss. 6, pp. 824-824
Open Access | Times Cited: 244
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi, Mazen Noureddin, Naim Alkhouri, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 6, pp. 373-392
Closed Access | Times Cited: 231
Obesity and nonalcoholic fatty liver disease: current perspectives
Raiya Sarwar, Nicholas Pierce, Sean Koppe
Diabetes Metabolic Syndrome and Obesity (2018) Vol. Volume 11, pp. 533-542
Open Access | Times Cited: 216
Impaired Sensitivity to Thyroid Hormones Is Associated With Diabetes and Metabolic Syndrome
Martín Laclaustra, Belén Moreno‐Franco, José Manuel Lou-Bonafonte, et al.
Diabetes Care (2018) Vol. 42, Iss. 2, pp. 303-310
Open Access | Times Cited: 208
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
Rohit A. Sinha, Eveline Bruinstroop, Brijesh Kumar Singh, et al.
Thyroid (2019) Vol. 29, Iss. 9, pp. 1173-1191
Open Access | Times Cited: 204
Microplastics enhance the developmental toxicity of synthetic phenolic antioxidants by disturbing the thyroid function and metabolism in developing zebrafish
Huajin Zhao, Jiankang Xu, Zehua Yan, et al.
Environment International (2020) Vol. 140, pp. 105750-105750
Open Access | Times Cited: 164
The role of thyroid hormone in metabolism and metabolic syndrome
Patrícia de Fátima dos Santos Teixeira, Patrícia Borges dos Santos, Carmen C. Pazos‐Moura
Therapeutic Advances in Endocrinology and Metabolism (2020) Vol. 11
Open Access | Times Cited: 149
Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis
Heng Li, Xiao-Hua Yu, Xiang Ou, et al.
Progress in Lipid Research (2021) Vol. 83, pp. 101109-101109
Closed Access | Times Cited: 148
Thyroid Hormone Signaling and the Liver
Megan Ritter, Izuki Amano, Anthony N. Hollenberg
Hepatology (2020) Vol. 72, Iss. 2, pp. 742-752
Closed Access | Times Cited: 144
Virus Infections and Host Metabolism—Can We Manage the Interactions?
Deepak Sumbria, Engin Berber, Manikannan Mathayan, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 114
Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis
Qi Wang, Haoming Zhou, Qingfa Bu, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 2, pp. 312-325
Open Access | Times Cited: 93
Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance
Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 6, pp. 1524-1541
Open Access | Times Cited: 77
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD
Kathleen Clare, John Dillon, Paul Brennan
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 5, pp. 939-946
Open Access | Times Cited: 70
Resmetirom: An Orally Administered, Small-molecule, Liver-directed, β-selective THR Agonist for the Treatment of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
Gres Karim, Meena B. Bansal
touchREVIEWS in Endocrinology (2023) Vol. 19, Iss. 1, pp. 60-60
Open Access | Times Cited: 66
Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study
Jesse A. Goodrich, Douglas I. Walker, Jingxuan He, et al.
Environmental Health Perspectives (2023) Vol. 131, Iss. 2
Open Access | Times Cited: 46
Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Maximilian Huttasch, Michael Roden, S. Kahl
Metabolism (2024) Vol. 157, pp. 155937-155937
Open Access | Times Cited: 29
Metabolic Messengers: Thyroid Hormones
Rohit A. Sinha, Paul M. Yen
Nature Metabolism (2024) Vol. 6, Iss. 4, pp. 639-650
Open Access | Times Cited: 19
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19
A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism
Leonidas H. Duntas, Gabriela Brenta
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 159
Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Alessandro Mantovani, Fabio Nascimbeni, Amedeo Lonardo, et al.
Thyroid (2018) Vol. 28, Iss. 10, pp. 1270-1284
Closed Access | Times Cited: 127
Thyroid hormones in diabetes, cancer, and aging
Benoit R. Gauthier, Alejandro Sola‐García, María Ángeles Cáliz‐Molina, et al.
Aging Cell (2020) Vol. 19, Iss. 11
Open Access | Times Cited: 111
Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases
Christoffer Clemmensen, Brian Finan, Timo D. Müller, et al.
Nature Reviews Endocrinology (2018) Vol. 15, Iss. 2, pp. 90-104
Closed Access | Times Cited: 103
Page 1 - Next Page

Scroll to top